Back to customer servicesClinicians

Explore sourced public developments in medicine and clinical AI.

Read research, guidance, regulatory or technical developments without commissioning private case or research work.

How does this scope address your concerns?

Are sources, dates and evidence types clear, rather than old findings repackaged as today’s news?

When this scope fits

Public research and news reading
No private-case processing, independent study or individual professional review needed

When the scope needs adjusting

Case applicability checks: commission complex-case review
Data, analysis results or paper research: commission a module or complete study

REAL SOURCES · ILLUSTRATIVE REQUEST · DOWNLOADABLE SAMPLE

Free evidence reading: kidney, oncology and rare disease

Download sample packZIP

Source type and reading use

01Kidney · guideline status

KDIGO: published 2024 guidance; focused update underway

02Oncology · study

OPRA: 2024 long-term follow-up and organ-preservation endpoint

03Rare disease · regulator

FDA: Itvisma approval announcement of 24 Nov 2025

An editorial sample using dated historical sources, not a claim of three new developments this week. Updates underway differ from published recommendations.

Check	Finding / sample content	Use
Kidney card	Check the guidance version and original studies	Label guidance/update status and retain scan date
Oncology card	Explain organ-preservation separately from survival	Label original research and link its report
Rare-disease card	The announcement distinguishes product and age criteria	Label regulatory news rather than individual efficacy comparison

SOURCES USED IN THIS EXAMPLE

Prepared 5 Oct 2026 · Selected references, not an exhaustive systematic search

Scope & acceptance

Work covered by the quote

Public reading · free

Public Frontiers & News, evidence reading and original-source links.
No charge for public reading, topic preferences or a private-library subscription.

Reading does not turn into a paid service automatically. Separately approved case or research work is quoted independently.

All-paper full-text rights, private-case processing, specialist consultations and independent research execution are excluded.

Acceptance criteria

Each item retains sources, dates and type. Historical examples are not today’s discoveries, and public reading is not case-specific advice.

Checking the evidence

Retain identifiable original sources, authorised inputs and missing information.

Workflow and inputs

From inputs to delivery

Explore the workflow and deliverable structure. This preview does not run searches, read real records or produce medical findings.

01 / WORKFLOW PREVIEW

Choose what to read

No subscription, private-library setup or record upload is required to explore public Frontiers & News.

Methods, sources and professional responsibilities

THE BASIS FOR THIS SCOPE

Why this approach? Inspect the basis.

Trace a clinical question to the research and distinguish effect size, certainty and the population.

PUBLIC DATABASE

PubMed

NLM / NIH

Check papers, abstracts and original sources

Find literature for a clinical question and inspect authors, publication dates, abstracts and full-text links.

Scope & access conditions

PubMed provides citations and abstracts, not journal full text. Access depends on the publisher or archive.

Read the official description

Open official source

PUBLIC DATABASE

Cochrane

Read systematic reviews and plain-language summaries

Explore a question’s research synthesis and the confidence researchers have in the findings.

Scope & access conditions

Plain-language summaries are public; full-review access varies. Applicability still depends on the population and question.

Open official source

METHOD REFERENCE

GRADE · Cochrane Handbook

Cochrane · Chapter 14

Show effect size and confidence separately

Present important outcomes, relative and absolute effects, available data and certainty, with reasons for downgrading.

Scope & access conditions

GRADE evaluates a body of evidence for a particular outcome. Database inclusion or one study does not automatically establish high certainty.

Open official source

These references support problem definition and evidence appraisal. Your conclusions still require project-specific sources and professional review.

Reuse and updates after delivery

Revisit sourced and dated reading without first purchasing a private library or subscription.

Agree reuse rights, retention and export periods, and future update fees when scoping.

Questions before commissioning

Is reading charged?

Public Frontiers & News and source links are free. Complex-case reviews and executed research tasks are separate paid commissions.

Are all full texts included?

No. Full-text access follows publisher permissions; the page provides permitted summaries and source links.

Can I directly apply an item to a patient?

Check the original population, outcomes and limits. Treating clinicians judge complex-case applicability; a separate review may be commissioned.

Define the delivery for your actual question.

Add your goal, available inputs and timing. Agree scope, review responsibilities and a quote before commissioning.

Request scope & quote

Explore other situations

Clinicians

Guidance has a conclusion, but a patient with comorbidities may not match its evidence.

Receive a patient–study–guidance crosswalk, applicability limits and agreed professional review records.

Quoted by case-review scopeSee the deliverable

Clinicians

A complex case needs evidence checked for this patient.

Receive case facts/gaps, an option–evidence applicability matrix, source locations and agreed review records.

Quoted by case-review scopeSee the deliverable

Clinicians

Authorized case or research data need a defined preparation or analysis stage completed.

Receive the scoped data module, issues and missingness, results, figures, code and reproduction handover.

Analysis module from CNY 3,000See the deliverable